Latest News about DEA
Recent news which mentions DEA
   Billions On The Move: Tracking Market Cap Changes In Top Cannabis Firms After DEA Rescheduling Announcement
   
  
  
  May 01, 2024
  From Benzinga
 
   DEA Moves To Reschedule Weed, Cannabis Stocks Go For Wild Ride, Pummel Short Sellers With $210M In Losses
   
  
  
  May 01, 2024
  From Benzinga
 From Benzinga
 
   Cannabis Stocks React To DEA Rescheduling: Canopy & Aurora Surge, Tilray, WM Tech Hold Steady
   
  
  
  April 30, 2024
  From Benzinga
 
   Rep Blumenauer On Marijuana Reclassification: 'Legalization Is Inevitable, Biden-Harris Admin Is Listening' To The People
   
  
  
  April 30, 2024
  From Benzinga
 
   DEA's Move To Reclassify Cannabis Seen As 'Significant,' But Fails To Resolve State-Federal Conflict
   
  April 30, 2024
  Tickers 
   DEA
  
  
  From Benzinga
 From Benzinga
 
   US Cannabis Council Call DEA Historic Decision To Reclassify Cannabis 'A Tectonic Shift'
   
  April 30, 2024
  Tickers 
   DEA
  
  
  From Benzinga
 
   Breaking: DEA Reportedly Moves To Reschedule Cannabis, Stocks Rise Sharply On The News
   
  
  
  April 30, 2024
  From Benzinga
 Tickers 
   DEA
  
  
  From InvestorPlace
 
   Senators Warren, Fetterman Plus 18 More Dems Tell DEA 'It's Time To Act' On Cannabis Rescheduling
   
  
  
  April 25, 2024
  From Benzinga
 
   DEA Sanctions Religious Use Of Ayahuasca But Refuses Psilocybin For Cancer Patients' Pain Relief
   
  
  
  April 24, 2024
  From Benzinga
 
   DEA Public Comment Period And A Cannabis-Related Crypto Bill? You Heard It First At Benzinga Conference
   
  
  
  April 19, 2024
  From Benzinga
 
   Analyst Reacts To FDA Commish Comments: Medical And Recreational Cannabis Could Have Separate Regulations
   
  
  
  April 12, 2024
  From Benzinga
 
   FDA Commissioner To House Committee: 'There's No Reason For DEA To Delay' Cannabis Rescheduling
   
  
  
  April 12, 2024
  From Benzinga
 
   Why Real Estate Stocks Were Hurting Today
   
  
  
  April 10, 2024
  From Motley Fool
 
   'This Is Insanity, Someone's Got To Act,' Marijuana Researcher Files Fed Lawsuit Against DEA Over 'Unconstitutional Process'
   
  
  
  April 10, 2024
  From Benzinga
 
   These Top REITs Have Yields Up to 9.1%
   
  
  
  April 09, 2024
  From Benzinga
 
   EXCLUSIVE: DEA-Licensed Cannabis Co. Maridose To Launch Series A Funding Round At Upcoming Benzinga Conference
   
  
  
  April 05, 2024
  From Benzinga
 
   DEA Revisits Proposed Ban On Two Psychedelic Compounds: Researchers Disagree, Insist On Hearings
   
  
  
  April 02, 2024
  From Benzinga
 From Benzinga
 
   DEA Comes Out Of The Shadows To Ensure Cannabis Rescheduling Process Is Not Being Done Under 'Shroud Of Secrecy'
   
  
  
  March 28, 2024
  From Benzinga
 
   GOP Mitt Romney Pens Letter To DEA Bashing Cannabis Rescheduling, Dems' Letter To DOJ Bashes Broken Promises
   
  
  
  March 27, 2024
  From Benzinga
 
   Rep. Blumenauer Grills Fed Health Agency For Clarity On Cannabis Rescheduling As Debate Heats Up
   
  
  
  March 21, 2024
  From Benzinga
 From Benzinga
 
   VP Kamala Harris Urges DEA To Reschedule Cannabis 'As Quickly As Possible,' Calls Prohibition 'Absurd' & 'Unfair'
   
  
  
  March 15, 2024
  From Benzinga
 From Benzinga
 
   GOP Sen. John Cornyn Takes Health Secretary To Task Over Cannabis Rescheduling: Xavier Becerra Holds His Own
   
  
  
  March 14, 2024
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.